
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6275730
[patent_doc_number] => 20100256130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'MORPHOLINYL AND PYRROLIDINYL ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 12/782752
[patent_app_country] => US
[patent_app_date] => 2010-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61632
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12782752
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782752 | MORPHOLINYL AND PYRROLIDINYL ANALOGS | May 18, 2010 | Abandoned |
Array
(
[id] => 9376070
[patent_doc_number] => 08680335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound'
[patent_app_type] => utility
[patent_app_number] => 12/782709
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 64
[patent_no_of_words] => 29855
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12782709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782709 | Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound | May 17, 2010 | Issued |
Array
(
[id] => 4634512
[patent_doc_number] => 08012963
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-06
[patent_title] => '3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/782280
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47904
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/012/08012963.pdf
[firstpage_image] =>[orig_patent_app_number] => 12782280
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782280 | 3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors | May 17, 2010 | Issued |
Array
(
[id] => 8802383
[patent_doc_number] => 08440657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => 'Substituted piperidines'
[patent_app_type] => utility
[patent_app_number] => 13/322593
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35780
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322593
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/322593 | Substituted piperidines | May 17, 2010 | Issued |
Array
(
[id] => 10851263
[patent_doc_number] => 08877945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Redox drug derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/319377
[patent_app_country] => US
[patent_app_date] => 2010-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11577
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319377
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/319377 | Redox drug derivatives | May 16, 2010 | Issued |
Array
(
[id] => 9401926
[patent_doc_number] => 08691979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants'
[patent_app_type] => utility
[patent_app_number] => 13/318907
[patent_app_country] => US
[patent_app_date] => 2010-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21536
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318907 | Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants | May 10, 2010 | Issued |
Array
(
[id] => 6350622
[patent_doc_number] => 20100249133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'APOPTOSIS PROMOTERS'
[patent_app_type] => utility
[patent_app_number] => 12/772951
[patent_app_country] => US
[patent_app_date] => 2010-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18369
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249133.pdf
[firstpage_image] =>[orig_patent_app_number] => 12772951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/772951 | Apoptosis promoters | May 2, 2010 | Issued |
Array
(
[id] => 9375829
[patent_doc_number] => 08680093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1'
[patent_app_type] => utility
[patent_app_number] => 13/318271
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 85070
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318271
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318271 | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 | Apr 29, 2010 | Issued |
Array
(
[id] => 9375829
[patent_doc_number] => 08680093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1'
[patent_app_type] => utility
[patent_app_number] => 13/318271
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 85070
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318271
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318271 | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 | Apr 29, 2010 | Issued |
Array
(
[id] => 6351935
[patent_doc_number] => 20100331320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1'
[patent_app_type] => utility
[patent_app_number] => 12/771499
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 85085
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331320.pdf
[firstpage_image] =>[orig_patent_app_number] => 12771499
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/771499 | CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 | Apr 29, 2010 | Abandoned |
Array
(
[id] => 9375829
[patent_doc_number] => 08680093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1'
[patent_app_type] => utility
[patent_app_number] => 13/318271
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 85070
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318271
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318271 | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 | Apr 29, 2010 | Issued |
Array
(
[id] => 9375829
[patent_doc_number] => 08680093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1'
[patent_app_type] => utility
[patent_app_number] => 13/318271
[patent_app_country] => US
[patent_app_date] => 2010-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 85070
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318271
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318271 | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 | Apr 29, 2010 | Issued |
Array
(
[id] => 7756895
[patent_doc_number] => 20120028970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/263809
[patent_app_country] => US
[patent_app_date] => 2010-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25906
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028970.pdf
[firstpage_image] =>[orig_patent_app_number] => 13263809
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/263809 | HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE | Apr 26, 2010 | Abandoned |
Array
(
[id] => 6447446
[patent_doc_number] => 20100280019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'ISOXAZOLES'
[patent_app_type] => utility
[patent_app_number] => 12/766125
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9879
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280019.pdf
[firstpage_image] =>[orig_patent_app_number] => 12766125
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/766125 | ISOXAZOLES | Apr 22, 2010 | Abandoned |
Array
(
[id] => 10857581
[patent_doc_number] => 08883780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Crystal of a benzoxazinone compound'
[patent_app_type] => utility
[patent_app_number] => 13/265599
[patent_app_country] => US
[patent_app_date] => 2010-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5241
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265599
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265599 | Crystal of a benzoxazinone compound | Apr 21, 2010 | Issued |
Array
(
[id] => 6536544
[patent_doc_number] => 20100204200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'INHIBITORS OF CATHEPSIN S'
[patent_app_type] => utility
[patent_app_number] => 12/764772
[patent_app_country] => US
[patent_app_date] => 2010-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 34607
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204200.pdf
[firstpage_image] =>[orig_patent_app_number] => 12764772
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/764772 | INHIBITORS OF CATHEPSIN S | Apr 20, 2010 | Abandoned |
Array
(
[id] => 6576298
[patent_doc_number] => 20100273785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => '2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/764249
[patent_app_country] => US
[patent_app_date] => 2010-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22487
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273785.pdf
[firstpage_image] =>[orig_patent_app_number] => 12764249
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/764249 | 2,5-disubstituted arylsulfonamide CCR3 antagonists | Apr 20, 2010 | Issued |
Array
(
[id] => 8152142
[patent_doc_number] => 08168628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Conjugated psychotropic drugs and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/764124
[patent_app_country] => US
[patent_app_date] => 2010-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 39
[patent_no_of_words] => 24852
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12764124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/764124 | Conjugated psychotropic drugs and uses thereof | Apr 20, 2010 | Issued |
Array
(
[id] => 32779
[patent_doc_number] => 07790714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-07
[patent_title] => 'Oxadiazoanthracene compounds for the treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/759010
[patent_app_country] => US
[patent_app_date] => 2010-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47130
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/790/07790714.pdf
[firstpage_image] =>[orig_patent_app_number] => 12759010
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/759010 | Oxadiazoanthracene compounds for the treatment of diabetes | Apr 12, 2010 | Issued |
Array
(
[id] => 6190135
[patent_doc_number] => 20110172419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES'
[patent_app_type] => utility
[patent_app_number] => 12/741067
[patent_app_country] => US
[patent_app_date] => 2010-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2682
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741067 | PROCESS FOR THE SYNTHESIS OF CYCLIC CARBAMATES | Apr 8, 2010 | Abandoned |